Company Data
Kazia Therapeutics Limited
Ticker
KZIA
Current Price
$11.43 5.83%
Market Cap
$15.5M
Price Target
Refer to Report
Volume
153.6K
52wk Range
$2.86 - $203.75
Overview
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others.